Roche.
Roche is leaving the Pharmaceutical Research & Manufacturers of America trade association effective June 30.
Roche describes the action as a "business decision" by "the newly combined Genentech-Roche US commercial organization."
According to the Pink Sheet, "As a practical matter, the departure will add to the strain on PhRMA for resources as it works on all fronts to build alliances and promote its reform agenda. The pending mergers of Pfizer/Wyeth and Merck/Schering-Plough will further reduce the group's core member base. The association traditionally adjusts dues following periods of consolidation."